先健科技(01302.HK)公佈年度業績 剔除若干非經常性項目純利增長76.8%至3.24億元 海外銷售額增長46.4%
格隆匯3月30日丨先健科技(01302.HK)發佈公吿,截至2021年12月31日止年度,公司收益9.25億元人民幣,同比增長44.1%;毛利約7.5億元,同比增長45.7%;剔除若干非經常性項目,公司擁有人應占純利3.24億元,同比增長76.8%。
收入增長主要歸因於覆膜支架、Cera封堵器及LAmbre左心耳封堵器的銷售收益增加。
較2020年同期,公司國內銷售額增長43.6%,主要得益於中國內地的新冠疫情形勢已經得到遏制,經濟活動在採納嚴格的疫情控制措施後重新恢復;公司產品於國內市場的滲透率提高。儘管大部分海外市場的新冠疫情形勢仍不穩定,集團的海外銷售額與2020年同期相比仍增長46.4%,其主要得益於公司採取有效的海外市場營銷策略。
知識產權為集團的重要無形資產,亦為公司提升於醫療器械市場核心競爭力的內在驅動力。該年度,集團已提交252項專利申請且156項專利獲批准。於2021年12月31日,集團累計已提交1529項專利申請,其中584項獲批准。
於2022年,集團將繼續密切關注疫情最新發展,有效加強成本及營運資金管理,以確保公司可持續發展。同時,公司將以審慎務實的準則營運公司的現有業務,積極尋找可使股東利益最大化的投資機會,並透過擴大收入來源以分散業務風險。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.